Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vaxcyte, Inc. | 104,395 | reported | 09 Mar 2026 | tx 167+1,422,277−653,679 |
| NEOFORMA INC | 66,338 | reported | 29 Jul 2005 | tx 8+70,462−2,000 |
| Caribou Biosciences, Inc. | 45,000 | reported | 20 Feb 2026 | tx 5+174,000 |
| Metacrine, Inc. | 16,500 | reported | 18 May 2022 | tx 2+33,000 |
| PROTEIN DESIGN LABS INC/DE | 13,255 | reported | 18 Dec 2008 | tx 8+152,500−4,245 |
| Dermira, Inc. | 0 | reported | 20 Feb 2020 | tx 73+612,265−682,471.51 |
| FACET BIOTECH CORP | 0 | reported | 21 Apr 2010 | tx 13+175,591−178,207 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | TAX_WITHHOLDING | Vaxcyte, Inc. | 1,021 | 59.32 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | Vaxcyte, Inc. | 1,009 | 61.98 USD | |
| 28 Feb 2026 | TAX_WITHHOLDING | Vaxcyte, Inc. | 898 | 61.98 USD | |
| 26 Feb 2026 | GRANT_AWARD | Vaxcyte, Inc. | 44,864 | 0.00 USD | |
| 26 Feb 2026 | GRANT_AWARD | Vaxcyte, Inc. | 74,993 | 0.00 USD | deriv |
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 45,000 | 0.00 USD | deriv |
| 14 Jan 2026 | GIFT | Vaxcyte, Inc. | 61,850 | 0.00 USD | |
| 14 Jan 2026 | GIFT | Vaxcyte, Inc. | 61,850 | 0.00 USD | |
| 08 Sept 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 2,890 | 32.41 USD | |
| 02 Sept 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 1,429 | 31.56 USD | |
| 02 Sept 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 2,381 | 31.56 USD | |
| 02 Sept 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 1,270 | 31.56 USD | |
| 07 Apr 2025 | EXERCISE | Vaxcyte, Inc. | 4,777 | 20.93 USD | |
| 07 Apr 2025 | EXERCISE | Vaxcyte, Inc. | 4,777 | 0.00 USD | deriv |
| 27 Feb 2025 | GRANT_AWARD | Vaxcyte, Inc. | 22,761 | 0.00 USD | |
| 03 Mar 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 3,809 | 72.10 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | Vaxcyte, Inc. | 1,270 | 73.02 USD | |
| 27 Feb 2025 | GRANT_AWARD | Vaxcyte, Inc. | 75,991 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Caribou Biosciences, Inc. | 40,500 | 0.00 USD | deriv |
| 18 Feb 2025 | EXERCISE | Vaxcyte, Inc. | 8,000 | 5.35 USD | |
| 18 Feb 2025 | SALE | Vaxcyte, Inc. | 6,182 | 83.64 USD | |
| 18 Feb 2025 | SALE | Vaxcyte, Inc. | 1,818 | 84.58 USD | |
| 18 Feb 2025 | EXERCISE | Vaxcyte, Inc. | 8,000 | 0.00 USD | deriv |
| 21 Jan 2025 | EXERCISE | Vaxcyte, Inc. | 8,000 | 5.35 USD | |
| 21 Jan 2025 | SALE | Vaxcyte, Inc. | 5,318 | 86.08 USD |